A recently concluded research study attempted investigating the relationship between migraine and obstructive sleep apnea in the general population.

In this cross-sectional population-based study, a random age and gender stratified sample of 40,000 persons aged 20–80 years residing in Akershus, Hedmark or Oppland County, Norway, were drawn by the National Population Register.

A postal questionnaire containing the Berlin Questionnaire was used to classify respondents to be of either high or low risk of obstructive sleep apnea. 376 persons with high risk and 157 persons with low risk of sleep apnea aged 30–65 years were included for further investigations. Read the rest of this entry

Obstructive sleep apnea (OSA) remains underdiagnosed, despite our understanding of its impact on general health.
Current screening methods utilize either symptoms or physical exam findings suggestive of OSA, but not both. The purpose of this study was to develop a novel screening tool for the detection of OSA, the NAMES assessment (neck circumference, airway classification, comorbidities, Epworth scale, and snoring), combining self-reported historical factors with physical exam findings.

Subjects were adults without previously diagnosed OSA, referred to a community sleep center for suspicion of OSA. Read the rest of this entry

SomnoMed Limited , the world’s leading oral appliance medical company announced today that US government health insurance programs have now recognized an oral appliance treatment as a valid medical treatment option for obstructive sleep apnea and medicare patients in the US will be covered for the oral appliance treatment.

SomnoMed, with its No. 1 sleep apnea appliance SomnoDent(R) MAS, will benefit from this new regulation, as patients can now have a SomnoDent(R) MAS as a first line treatment, without the requirement to “fail” a CPAP treatment.

SleepApneaDisorder/[ Press Release ]/ HONG KONG, Feb. 9, 2011 /- Ventus Medical, a privately-held United States based medical device company focused on sleep-disordered breathing, is pleased to announce that its proprietary Provent(R) Sleep Apnea Therapy, an innovative, non-invasive treatment for obstructive sleep apnea, is now available throughout Hong Kong. The HomeCare Medical Ltd., with over 17 years of sleep medicine experience, will be the exclusive distributor of Provent Sleep Apnea Therapy in Hong Kong.

We believe clinically-proven Provent Therapy offers a unique and convenient alternative to CPAP treatment for the large number of people in Hong Kong currently affected by obstructive sleep apnea,” said Philip Westbrook, M.D., chief medical officer of Ventus Medical and former President of the American Academy of Sleep Medicine. “Provent has been used effectively in the United States since 2008 and in clinical studies, Provent Therapy increased energy and quality of life while it reduced apnea (breathing disruptions), daytime sleepiness and related snoring. Importantly, Provent is easy to use, portable and discreet for use at home or when travelling.”

In patients with obstructive sleep apnea (OSA), the airway collapses during sleep when the muscles that hold it open relax. People with this disorder stop breathing during the night—in some cases hundreds of times each night — usually for periods of ten seconds or longer. Although some people with sleep apnea don’t know they have the condition, they snore and occasionally wake up gasping for air. It is often their sleep partner who is aware of these symptoms and will urge them to go to the doctor. Read the rest of this entry

About a quarter-million people in the Charlotte area are Medicare patients, and many of them have been or will be affected by a new system that significantly limits their provider choices for certain services. Members of Congress, caretakers and patients are already raising red flags, claiming the new system is flawed. 

Marilyn Graham said she is concerned about how well Medicare patients will be able to navigate the new system. She has a condition called sleep apnea and uses a continuous positive airway pressure machine — known as a CPAP machine — to help her breathe at night. 

In mid-January, she accidentally tore the face mask, which pumps oxygen into her lungs. Graham called her provider but was told the business couldn’t help her anymore because it didn’t win a Medicare competitive bidding contract for CPAP machines. Read the rest of this entry

New Implant Device For Treatment of Central Sleep Apnea

A central Ohio man has become the first person in the United States to receive an implant being studied for the treatment of central sleep apnea in heart failure patients by delivering small electrical impulses during sleep to restore more natural breathing. The procedure was performed at The Ohio State University Medical Center’s Richard M. Ross Heart Hospital.

“After a successful proof-of-concept study at Ohio State and a small number of sites in China, Poland and Germany, the implant translates concept to reality,” says Dr. William Abraham, director of the division of cardiovascular medicine at Ohio State’s Medical Center, and principal investigator of the safety and feasibility trial. “The potential of this therapy is substantial, given the very high prevalence of central sleep apnea in heart failure patients.” Read the rest of this entry

Lundbeck Signs Commercial Deal With Cephalon

COPENHAGEN, Feb 8 (Reuters) – Danish drugmaker Lundbeck has signed a commercial rights deal with biotechnology firm Cephalon Inc in Canada and Latin America to reinforce its position in those markets.

Under the deal, Lundbeck will take over the registration and commercial rights to a number of Cephalon products such as Provigil and Nuvigil to improve wakefulness, and its pain product Fentora, Lundbeck said on Tuesday.

“The Cephalon brands will significantly strengthen our position in these markets while leveraging on existing sales and marketing capabilities adding significant sales in Canada and Latin America from 2012,” Lundbeck’s Chief Executive Ulf Wiinberg said in the statement. Read the rest of this entry

A New York Times report examined how poor sleep and susceptibility to colds go hand in hand, and scientists think it could be a reflection of the role sleep plays in maintaining the body’s defenses.

Most people with sleep apnea are aware that they snore and feel overtired or fatigued but are unaware of potentially serious medical problems that include memory loss, stroke, heart disease and an increase risk of auto accidents.

In a study for The Archives of Internal Medicine, scientists followed 153 men and women for two weeks, keeping track of their quality and duration of sleep. After exposure to the cold viruses, those who slept an average of fewer than seven hours a night were three times as likely to get sick. If you have Obstructive Sleep Apnea or are NOT using your CPAP, Find a Sleep Apnea Treatment Center near your locality.
Read the rest of this entry

The National Sleep Foundation (NSF) is pleased to announce that “Sleep and Communications Technology Use” will be the topic of its 2011 Sleep in America™ poll. NSF will release the poll results on March 7, 2011 to kick-off National Sleep Awareness Week®. An embargoed press release will be available on February 28, 2011.

This will be the first Sleep in America™ poll dedicated to exploring communications technology use in 13-64 year olds within the hour before going to sleep. It will compare texting, computer, television, phone and video game habits of generation Z, millennials, generation-Xers and baby boomers, and will examine the following questions:

  • Does communications technology use at bedtime affect sleep, and how do different age groups compare?
  • Do sleep habits, including wake and bed time routines, vary by age?
  • How frequent is napping and caffeine use in teens and adults?
  • How many people say they are driving drowsy, and is there a connection with their bedtime habits or electronics use at night? Read the rest of this entry

Pillar Procedure:Technique To Cure Snoring and Sleep Apnea

SleepApneaDisorder/ [ Press Release ]/ New York, NY /February 4, 2011/ The Pillar® Procedure, which is a relatively new in-office medical technique, is being touted among snoring specialists as a cure for snoring in many patients. As more snorers are being treated with this procedure worldwide, positive results lasting many years are being realized.

The Pillar Procedure is a minimally invasive, simple and safe treatment for snoring and safe treatment for mild to moderate Obstructive Sleep Apnea and snoring caused by the fluttering of the soft palate while asleep. It’s a relatively painless procedure that can be performed in a doctor’s office in about 20 minutes, using only local anesthetic. Read the rest of this entry

Related Posts with Thumbnails